The intravenous infusion pumps market consists of sales of intravenous infusion pumps and related services by entities (organizations, sole traders and partnerships) that manufacture intravenous infusion pumps. An intravenous infusion pump is a medical device that provides regulated quantities of fluids, such as nutrients and medicines, into the body of the patient.
The global intravenous infusion pumps market is expected to grow from $1.87 billion in 2019 to $2.27 billion in 2020 at a compound annual growth rate (CAGR) of 21.43%. The growth is mainly due to the COVID-19 outbreak that has increased the demand for intravenous infusion pumps to treat the affected patients. The market is then expected to stabilize and reach $2.36 billion in 2023 from 2021 at a CAGR of 1.28%.
